Regeneron drug for disease that causes dangerous bone growth earns FDA approval
Regeneron drug for disease that causes dangerous bone growth earns FDA approval STAT
Finance, IT & News
Regeneron drug for disease that causes dangerous bone growth earns FDA approval STAT
US FDA approves Regeneron's rare bone disorder drug Reuters
The U.S. Food and Drug Administration today authorized the Aletta, the first standalone robotic device that can draw blood from…
The U.S. Food and Drug Administration today issued an accelerated approval for Genglycos (pariglasgene brecaparvovec-opnr) as the first-ever treatment for…
Fitch affirms Mongolia at ’B+’ on mining growth, external risks By Investing.com Investing.com South Africa